Melina Mathur - Profile and Investment Details

Investor Profile

Melina Mathur is a Venture Capital, Micro VC based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as Indi Molecular, ICON Aircraft, CardioGen Sciences, Chimerix, CardioDx, Esperion Therapeutics, LiquidM, The Activity Exchange (AchieveMint), Signal Vine, Provade, Inc., Proteus Digital Health, OfferIQ, Carta Healthcare, RallyPoint, Welldoc, Freenome, Audentes Therapeutics, InCarda Therapeutics, Rapidscan Pharma Solutions, Unnatural Products, Maverix Biomics, Huiseoul, HealthTap, Tradeo, Arterys, Ooma, Mightier, ViewPoint Therapeutics, Aegis Surgical, Benefitter, Properly, Biomimedica, Asset Management Ventures, Profusa, Thunder, Mozio, Sensomics, Ginkgo Bioworks, Inc.Amygdala Neuroscience, ImmunoCellular Therapeutics, Outcomes4Me, Evidation Health, Lark, Womply, Twist Bioscience, Terra Bella, UniKey Technologies, Keepsafe, Stanford University School of Medicine, HighTower Advisors, Welkin Health, 1DocWay, 3T Biosciences, Synecor, Decent, Secure AI Labs, Reify Health, . Over time, Melina Mathur has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Melina Mathur is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Cybersecurity, Wellness, Women Founded, Consumer Goods, Apps, Life Science, Engineering, UX Tools, Artificial Intelligence (AI), Information Technology (IT), Analytics, Internet of Things (IoT), Mobile, Synthetic Biology, Automation, Software, Manufacturing, Biotechnology, Innovation, Clinical Trials, Research, Agriculture, Hardware, Insurance, Logistics, Renewable Energy, Medical, B2B, Machine Learning, Personal Health, Pharmaceuticals, DNA Synthesis may find it worthwhile to explore potential connections with Melina Mathur, as their portfolio suggests a familiarity and interest in this area.

Understanding Melina Mathur’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.